• Profile
Close

Topical citicoline and vitamin B12 vs placebo in the treatment of diabetes-related corneal nerve damage: A randomized double-blind controlled trial

BMC Ophthalmology Aug 07, 2020

Fogagnolo P, Melardi E, Tranchina L, et al. - Researchers, for the first time, conducted this prospective, randomized, double blind, placebo-controlled study to assess the impacts of topical citicoline and vitamin B12 (Cit-B12: OMK2, Omikron Italia srl, Italy) on corneal innervation of patients with diabetic neuropathy. For this analysis, 30 patients randomized with a 2:1 ratio to Cit-B12 or placebo 3 times daily for 18 months. The study concluded with 29/30 patients. In patients with diabetes, Cit-B12 improved both morphology and function of the corneal nerves, suggesting a neuroregenerative effect.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay